Aarti Drugs Invests ₹80.5 Million for 26.25% Stake in Green Power Venture

Aarti Drugs Ltd, a prominent player in the pharmaceutical industry, has made a strategic move into the renewable energy sector. The company has announced its decision to acquire a 26.25% equity stake in Pro-Zeal Green Power Nine1, with a total investment of 80.5 million rupees. This significant acquisition underscores Aarti Drugs' commitment to sustainable practices and marks its entry into the green energy market. The investment is expected to enhance the company's environmental profile while potentially offering long-term financial benefits through cost savings and new revenue streams. This move aligns with the growing trend of pharmaceutical companies investing in renewable energy to reduce their environmental impact.

Source: Business Standard